Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, January 28, 2026

Gout drug could reduce stroke risk, study suggests

 

Ask your competent? doctor to compare all this research for the best course of action.

 

Gout drug could reduce stroke risk, study suggests

A gout drug taken at the right dose may cut heart attack and stroke risk in people with gout, a study of 109,504 patients in the UK, Sweden and Italy suggests.

Gout is a common arthritis caused by uric acid crystals forming in joints, triggering sudden severe pain, often in the big toe, feet, ankles, hands, wrists, elbows and knees.

Medicines such as allopurinol lower uric acid and can dissolve crystals when dosed correctly, which varies by person. Patients are usually advised to aim for under 360 micromol/L in blood.

Gout has been linked with a higher risk of cardiovascular disease, including heart attacks and stroke.

Researchers analysed Clinical Practice Research Datalink Aurum records linked to hospital and mortality data from January 2007 to March 2021.

All participants were 18 or over, had gout and had uric acid levels above target before treatment.

They were split into two groups, one prescribed urate-lowering drugs, mainly allopurinol.

Researchers then assessed heart attacks, strokes or death from heart problems within five years of the first prescription.

Those on medication had a lower risk of heart problems over five years and fewer gout flares. Risks fell further in patients who achieved uric acid below 300 micromol/L.

University of Nottingham’s professor Abhishek Abhishek, who led the study, said: “People with gout are at an increased risk of illnesses such as heart disease and stroke.

“This is the first study to find that medicines such as allopurinol that are used to treat gout reduce the risk of heart attack and stroke if they are taken at the right dose.”

“The right dose varies from person to person and is the dose that gets the blood urate level to less than 360 micromol/L (6 mg/dL).”

He described the findings as “very positive.”

He added: “Previous research from Nottingham showed treat-to-target urate-lowering treatment prevents gout flares.”

“This current study provides an added benefit of reduced risk of heart attack, stroke, and death due to these diseases.”

The UK Gout Society estimates gout affects around one in 40 people in the UK.

Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)